About John C. Moore

John C. Moore has more than 25 years of executive experience at several ophthalmic medical device companies, where he successfully managed R&D;, operations, marketing, sales, business development, service, and finance teams. Most recently Mr. Moore served as CEO of Notal Vision, an Israeli-based company that developed comprehensive diagnostic solutions for the early detection and monitoring of age-related macular degeneration.

Read More


Prior to Notal Vision, Mr. Moore served as the President and CEO of Laser Diagnostic Technologies, a manufacturer of diagnostic laser scanning ophthalmoscopes used for the early detection of glaucoma, which was acquired by Carl Zeiss Meditec, Inc. in 2004. Before this, Mr. Moore was a vice president at Alcon Laboratories where he was responsible for pursuing and executing strategic acquisitions and partnerships to broaden the company's product portfolio.

Mr. Moore also spent more than 10 years at Carl Zeiss, Inc., a $2 billion multinational company with primary businesses in optics, medical, scientific and semiconductor products. While at Carl Zeiss Mr. Moore identified and executed the acquisition of Humphrey Instruments, a manufacturer of ophthalmic diagnostic instruments and subsequently served as the division's President and CEO. Prior to this, Mr. Moore served as vice president and general manager at Carl Zeiss Medical, a division of Carl Zeiss, Inc. Mr. Moore began his career in ophthalmic medical devices at Coherent, Inc., a laser manufacturer for the industrial, medical and scientific industries.

Mr. Moore has previously served on the Boards of two ophthalmic industry groups, the Glaucoma Foundation and the Blindness Prevention of America, and currently serves on the Boards of Directors of Optovue, a pioneering maker of optical coherence tomography (OCT) imaging tools,STAAR Surgical, and Notal Vision.

  1. Mentioned In 5 Articles

  2. John Moore Appointed to Staar Surgical Board Of Directors

    Healthcare Sales & Marketing Network (Jan 14 2008) Ophthalmology Explore Article

    ...f minimally invasive ophthalmic products, today announced that its Board of Directors has appointed John C. Moore (63) as a new independent board member. Mr. Moore's appointment fills the vacancy on STAAR's left b... (Read Full Article)

    Comment on Article Mentions:   Optovue   John C. Moore   Carl Zeiss Meditec

  3. John Moore Appointed to Staar Surgical Board Of Directors

    money.cnn.com (Jan 14 2008) Ophthalmology Explore Article

    ...tovue, a pioneering maker of optical coherence tomography (OCT) imaging tools and Notal Vision. ... John Moore Appointed to STAAR Surgical Board Of Directors MONROVIA, Calif., Jan. 14 /PRNewswire-FirstCall/ -- ......f minimally invasive ophthalmic products, today announced that its Board of Directors has appointed John C. Moore (63) as a new independent board member. Mr. Moore's appointment fills the vacancy on STAAR's left b... (Read Full Article)

    Comment on Article Mentions:   Optovue   John C. Moore   Carl Zeiss Meditec

  4. Optovue raises $10.5M

    bizjournals (Mar 30 2007) Ophthalmology , Funding Explore Article

    ...ed States, as well as advance development of the company's product pipeline. Optovue also appointed John Moore, forme Ophthalmic device maker Optovue Corp. said Friday it received $10.5 million in second-round ... (Read Full Article)

    Comment on Article Mentions:   Optovue   John C. Moore   Jay Wei

  5. Carl Zeiss Meditec to acquire Laser Diagnostic Technologies

    Ophthalmology Times (Oct 23 2004) Ophthalmology , Acquisition Explore Article

    ...gressive growth through pursuit of both internal and external potentials." LDT President and CEO John Moore noted that this deal is a reflection of the successful evolution of the company's GDx technology. ... (Read Full Article)

    Comment on Article Mentions:   Carl Zeiss Meditec   John C. Moore   Zeiss Stratus OCT

  6. OCT-assisted surgical microscope with multi-coordinate manipulator

    PatFT » Page 1 of 1 (Aug 18 1998) Microscopy , Patents Explore Article

    Embodiments of the present invention provide method and apparatus for use during a neurosurgical procedure to enable a multi-coordinate manipulator ("MCM") to locate blood vessels and nerves in a patient's brain with submillimeter resolution. In addition, embodiments of the present invention provide method and apparatus for mapping oxygenation of brain tissue in three dimensions to differentiate tumor tissue from normal brain tissue with submillimeter resolution. (Read Full Article)

    Comment on Article Mentions:   Carl Zeiss Meditec   John C. Moore   Michael Kaschke

1-5 of 5
Home All Articles Entities Quotes Comments Login Register Powered by HiveFire